Kate-Louise Gottfried, JD, MSPH

Slides:



Advertisements
Similar presentations
Investigator Responsibilities in Clinical Research
Advertisements

The Role of the IRB An Institutional Review Board (IRB) is a review committee established to help protect the rights and welfare of human research subjects.
Managing Compliance Related to Human Subjects Research Review Joseph Sherwin, Ph.D. Office of Regulatory Affairs University of Pennsylvania Fourth Annual.
FDA Research: Clearance Requirements and Implications Steven L. Bradbard, Ph.D. Team Leader, Consumer Studies CFSAN/ORPSS.
TITLE OF PROJECT PROPOSAL NUMBER Principal Investigator PI’s Organization ESTCP Selection Meeting DATE.
Quality Improvement/ Quality Assurance Amelia Broussard, PhD, RN, MPH Christopher Gibbs, JD, MPH.
IRB Determinations 1. AAHRPP Site Visit Results Site visitors observed a real commitment to human subject protections Investigator and research staff.
Recently Issued OHRP Documents: Guidance on Subject Withdrawal and Draft Revised FWA Secretary’s Advisory Committee on Human Research Protections October.
1 FDA DRAFT GUIDANCE ON CLINICAL TRIAL DATA MONTORING COMMITTEES Susan S. Ellenberg, Ph.D. Office of Biostatistics and Epidemiology Center for Biologics.
Columbia University IRB IRB 101 September 21, 2005 George Gasparis, Executive Director, CU IRB Asst. V.P. and Sr. Asst. Dean for Research Ethics.
Research Proposal Development of research question
Special Topics in IND Regulation
Accredited Member of the Association of Clinical Research Professionals, USA Tips on clinical trials Maha Al-Farhan B.Sc, M.Phil., M.B.A., D.I.C.
Continuing Review VA Requirements Kevin L. Nellis, M.S., M.T. (A.S.C.P.) Program Analyst Program for Research Integrity Development and Education (PRIDE)
Federalwide Assurance Presentation for IRB Members.
International Environmental Health Conference Presented by: John S. Petterson, Ph.D. Director, Sequoia Foundation Sponsored by: Shanghai Health Bureau.
Adverse Events, Unanticipated Problems, Protocol Deviations & other Safety Information Which Form 4 to Use?
International Research & Research Involving Children K. Lynn Cates, MD Assistant Chief Research & Development Officer Office of Research & Development.
Institutional Review Board (IRB) Human Subject Dr. John N. Austin, Director and Ms. Renee S. Jones, Associate Director Delaware State University Office.
FAO/WHO Codex Training Package Module 3.2 FAO/WHO CODEX TRAINING PACKAGE SECTION THREE – BASICS OF NATIONAL CODEX ACTIVITIES 3.2 How to develop national.
United States Department of Agriculture Food Safety and Inspection Service 1 National Advisory Committee on Meat and Poultry Inspection August 8-9, 2007.
The NIH Grant Review Process Hiram Gilbert, Ph.D. Dept. of Biochemistry, Baylor College of Medicine Xander Wehrens, M.D. Ph.D. Dept. of Molecular Physiology.
1 Denise K. Thwing, MAS, RN, CCRA March 31, 2010 Version: Final 31-Mar-2010.
Scientific Merit Review René St-Arnaud, Ph.D. Shriners Hospital and McGill University CCAC National Workshop May 13, 2010, Ottawa (Ontario)
UC DAVIS OFFICE OF RESEARCH Overview of Good Clinical Practices (GCP) Investigator and Study Team Responsibilities Miles McFann IRB Administration Training.
PATIENT-CENTERED OUTCOMES RESEARCH INSTITUTE PCORI Board of Governors Meeting Washington, DC September 24, 2012 Anne Beal, MD, MPH, Chief Operating Officer.
Carilion Clinic, Office of Sponsored Projects Frequently Asked Questions Pre-Award Procedures For Principal Investigators.
Continuing Review Presented by: Karen Jeans, PhD, CCRN, CIP Program Analyst, COACH.
AAHRPP ACCREDITATION (Association for the Accreditation of Human Protection Programs)
Conducting Research at Lincoln IRB/HRPP Policies, Procedures & Good Clinical Practices B Kanna MD, MPH, FACP Associate Program Director of Internal Medicine.
Emerging SACHRP Issues K. Lynn Cates, MD Assistant Chief Research & Development Officer Director, PRIDE Office of Research & Development Department of.
INTERNATIONAL SCIENCE AND ENGINEERING FAIR Rules and Guidelines 2016.
 What is an IRB and why do we need one at Western?  Who needs to submit proposals to the IRB?  If approved, how long is your proposal good for?  Is.
THE INSTITUTIONAL REVIEW BOARD. WHAT IS AN IRB? An IRB is committee set up by an institution to review, approve, and regulate research conducted under.
Principal Investigator ESTCP Selection Meeting
Dr.V.Jaiganesh Professor
Scientific and Scholarly Validity
Research Compliance and Institutional Review Boards
NATA Foundation Student Grants Process
University of Central Florida Office of Research & Commercialization
Updating the Regulation for the JINR Programme Advisory Committees
Beverley Alberola, CIP Associate Director, Research Protections
FDA’s IDE Decisions and Communications
NATA Foundation General Grants Program Process
NSF/NIH Review Processes University of Southern Mississippi
MUHC Innovation Model.
Research with human participants at Carnegie Mellon University
Principal Investigator ESTCP Selection Meeting
Writing the research protocol
NSF/NIH Review Processes University of Southern Mississippi
Updates to Expedited Review Procedures
Updates to Expedited Review Procedures
Setting Actuarial Standards
University of Central Florida Office of Research & Commercialization
To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the screen changes and you.
Rick McGee, PhD and Bill Lowe, MD Faculty Affairs and NUCATS
Updates to Expedited Review Procedures
Promotion on the Clinician Educator and Clinical Practice Tracks
Russell Center Small Research Grants Program
IND Review Process Seoul National University
Generic Medical Device Company (“MDC”)
GSBM Presentation Updated
Project Title Subtitle: make sure you specify it is a research project
Overview of Process for GSEP Students
Principal Investigator ESTCP Selection Meeting
Human Participants Research
GPS IRB SIX STEPS Updated
Changes to the Common Rule and Single IRB (sIRB)
NATA Foundation General Grants Program Process
Principal Investigator ESTCP Selection Meeting
Presentation transcript:

Should We or Shouldn’t We: The Decision to Create a Scientific Review Committee Kate-Louise Gottfried, JD, MSPH Director, Office for Research Integrity Tufts-New England Medical Center Boston, MA Fourth Medical Research Summit April 22, 2004 4/21/2019

Scientific Review Committee Robert D Sege, MD PhD, Chair (NEMC*) Jerry Dallal, PhD (Tufts*) Patricia Hibberd, MD PhD (NEMC*) John Griffith, Ph.D (NEMC*) Susan Parsons, MD, MRP (NEMC*) Ex officio – IRB Chair, (NEMC*) Director of Research Integrity (NEMC/Tufts) * = Indicates the members primary appointments. 4/21/2019

SRC Composition Chairman, an MD 4 additional committee members 2 MD’s or MD/Ph.Ds 2 Ph.D statisticians 2 Ex officio members – IRB Chair, Director of Research Integrity (official institutional liaison) Expert reviewers on an as per needed basis 4/21/2019

Process Institutional officials in consultation w/chair identify potential members—strong methodological skills key Members are compensated Members terms – initial one year appointment; Members serve at the pleasure of the institutional officials 4/21/2019

Introduction What is the SRC? Which Protocols are Reviewed? What is the SRC Process? Tips on getting through the SRC 4/21/2019

Overview Federal regulations require the institution to be certain that all human studies research has scientific merit IRB focuses on ethical issues 4/21/2019

What is the SRC? The scientific Review Committee (SRC) established to reinforce institutional mission to promote research excellence. The SRC reviews selected clinical research proposals to ensure they meet acceptable standard of scientific rigor and merit prior to IRB review. 4/21/2019

SRC Procedures: Protocol Selection IRB staff and SRC select protocols for review. Goal: assure all research has had independent scientific review prior to going to the IRB. 4/21/2019

Examples of protocols NOT reviewed Federally funded Research e.g.,DoD; DoE; EPA; DHHS, AHRQ, CDC, FDA, NIH; DoJ,etc.. General Clinical Research Center protocols (GCRC) - approved by its Scientific Advisory Committee. Minimal Risk – Research that qualifies for expedited or exempt IRB review 4/21/2019

Other Exceptions Research funded by corporate, foundation/organization/association using an adequate peer review mechanism. The IRB and/or Institutional Officials may, at their discretion, forward any protocol to SRC at any point during review process. 4/21/2019

Investigator submits completed protocol to the IRB Exempt from SRC if Subject to Peer Review: NIH GCRC Large Multi-Center Trials Other (e.g., Found/Org/Assoc.) IRB staff assesses protocol: Determines if it had prior scientific peer review Proceeds through the Standard IRB Process NO YES Scientific Review Prior Scientific Review* Not Acceptable Acceptable Acceptable Returned to PI for:  Revision  PI defense to SRC Content Expert SRC Not Acceptable 4/21/2019

SRC Procedures: Protocol Review Meets weekly 2 Primary reviewers: MD and statistician Expert invited if necessary Review criteria on Tufts/Tufts-NEMC website 4/21/2019

PROTOCOL REVIEW AND MONITORING SYSTEM SCIENTIFIC REVIEW COMMITTEE PROTOCOL REVIEW AND MONITORING SYSTEM Protocol Review Form Scientific Reviewer Comments – (page 1 of 2) Title: PRINCIPAL INVESTIGATOR: Reviewer: Objectives: Clearly stated purpose of study Present/Acceptable Present/ Not Acceptable Absent Comment: Background and Rationale: Justification for conducting the study; results of similar or pilot data; current literature cited Present/Acceptable Present/ Not Acceptable Absent Design: Adequate to determine stated objectives Eligibility Criteria: Specific inclusion/exclusion requirements Outcome Characteristics and Endpoint Definitions: Statistical Analysis and Sample Size: Data Management: Data and Safety Management Plan: Present/Acceptable Present/ Not Acceptable Absent Overall Assessment: Forward to IRB for consideration Forward to IRB with comments Return to PI with comments Please summarize below at end of committee discussion what changes you request or questions you want conveyed to the PI: 4/21/2019

Content Experts Called for if specific question arises SRC chair notifies Division Chief Reviewers must Not be involved in protocol Be willing Be available to attend SRC meeting 4/21/2019

Content Experts (cont’d) Experts are requested to: Assess relevance of proposed study to the field; or Assess technical issues beyond expertise of committee members. Expert reviewer addresses specific questions posed by SRC members. Reviewer does not provide written comments. Reviewer excused prior to members discussion. 4/21/2019

SRC Procedures: Decisions Approved - sent to IRB for consideration Approved with stipulations – sent to IRB with comments Not yet approvable - return to PI 4/21/2019

SRC Experience to Date: Problem protocols: Often submitted by trainees Do not contain all relevant sections of a research protocol Measures do not match objectives Analytic plan missing or vague Concern about the validity of the scientific question 4/21/2019

Protocol Reviews 25 proposed studies reviewed by the SRC prior to the "go live" date (May 2003 thru January 2004) Since go live (2/1/04), five studies for SRC review Two studies awaiting review – 4/23/04 5 protocols reviewed since 2/1/04, 3 returned to PI; 2 forwarded to the IRB with comments 4/21/2019

Summary – SRC Process SRC provides independent scientific review of clinical protocols not previously reviewed SRC decisions are binding Procedures designed to minimize delay for acceptable protocols 4/21/2019

Expected Outcomes Enhance quality of research at Tufts & Tufts-NEMC -increase IRB protocols that result in published papers Referral to institutional clinical research resources for assistance -count the referrals from the SRC 4/21/2019

Expected Outcomes (cont’d) Eliminate initial IRB review of inadequate protocols: incomplete, poorly designed, improperly powered, etc. -eliminate deferrals for these reasons Enable the IRB to focus on ethical concerns -eliminate deferrals for scientific concerns 4/21/2019

No Pain, No Gain Data collection completed Working on the analysis Discover design flaw – after the fact UGH! Better to be Proactive v. Reactive: Input effort upfront 4/21/2019